In a securities fraud case, loss causation is the plaintiff’s burden to prove that the defendant’s misrepresentation actually caused the financial loss being claimed, not just that the stock was bought at an inflated price. Paying too much because of a lie is not, by itself, a recoverable injury. The loss arrives later, when the truth reaches the market and the share price falls, and the plaintiff has to draw a direct line between the two.
What Loss Causation Requires
The doctrine comes from proximate cause. The investor’s financial injury must be a foreseeable consequence of the defendant’s misrepresentation or omission, and the Supreme Court made that explicit in Dura Pharmaceuticals, Inc. v. Broudo (2005). Buying a stock at a price inflated by a lie does not, by itself, create a compensable loss. At the moment of purchase, the buyer holds shares worth exactly what was paid for them on the open market. No money has been lost yet.1Justia. Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005)
The actual harm comes when the truth reaches the market and the price drops. The Dura Court held that Congress intended private fraud actions to succeed only where the plaintiff proves “the traditional elements of causation and loss,” not merely that a misrepresentation existed when they bought shares.1Justia. Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005)
Section 21D(b)(4) of the Private Securities Litigation Reform Act codifies this burden. It states that “the plaintiff shall have the burden of proving that the act or omission of the defendant alleged to violate this chapter caused the loss for which the plaintiff seeks to recover damages.”2Office of the Law Revision Counsel. 15 USC 78u-4 – Private Securities Litigation Federal Rule of Civil Procedure 9(b) adds a second hurdle: fraud allegations must be pled “with particularity,” so vague causal theories get dismissed before discovery.3Legal Information Institute. Federal Rules of Civil Procedure Rule 9 – Pleading Special Matters
In practice, that means proving three links: a misstatement, a revelation that exposes it, and a price decline tied to the revelation. An investor who sells before the truth comes out will find loss causation nearly impossible to establish.
Transaction Causation Is Not the Same Thing
Securities fraud plaintiffs have to prove two different kinds of causation, and conflating them is a quick way to lose. Transaction causation asks whether the fraud induced the purchase or sale. Loss causation asks whether the fraud caused the financial loss. Both are required.
Transaction causation is about reliance. An individual plaintiff would usually need to show they read and relied on the misleading statement. In class actions involving publicly traded stocks, the fraud-on-the-market theory from Basic v. Levinson (1988) supplies a presumption of reliance: in an efficient market, public information is baked into the price, so anyone trading at that price relies on its integrity.4Justia. Halliburton Co. v. Erica P. John Fund, Inc., 573 U.S. 258 (2014)
Satisfying transaction causation does not satisfy loss causation. The Ninth Circuit’s model instructions capture the next step: the plaintiff must show that the revelation of the misrepresentation “was a substantial factor in causing a decline in the security’s price, thus creating an actual economic loss.”5Ninth Circuit District and Bankruptcy Courts. Manual of Model Civil Jury Instructions – 18.8 Securities Causation An investor tricked into buying who then never lost money has transaction causation and nothing more.
How Plaintiffs Prove Loss Causation
There are two main routes. One is to point to a corrective disclosure. The other is to show that the risk the defendant hid actually materialized.
Corrective Disclosures
The most common path is a corrective disclosure. Information reaches the market that reveals the earlier statement was false or misleading, and the stock price drops. The disclosure does not have to be a formal confession. A company admission, a regulator’s announcement of an investigation, an analyst report, or investigative journalism can all qualify, provided the new information is specific enough for a reasonable investor to connect it to the earlier misrepresentation.
Timing matters. Courts look for a tight link between the disclosure and the price drop. The further apart they are, the weaker the inference becomes.
Partial and Serial Disclosures
Fraud rarely unravels in a single moment. The Ninth Circuit has held that a corrective disclosure “need not reveal the full scope of the defendant’s fraud in one fell swoop; the true facts concealed by the defendant’s misstatements may be revealed over time.”5Ninth Circuit District and Bankruptcy Courts. Manual of Model Civil Jury Instructions – 18.8 Securities Causation Each partial disclosure that triggers a measurable price drop can independently support loss causation for the portion of the loss it caused.
The partial disclosure does not have to mirror the original misrepresentation precisely. It is enough that the new information, taken as true, renders some part of what the defendant previously said false or misleading.
The Leakage Theory
Leakage goes a step further. The plaintiff argues that corrective information seeped into the market gradually, through analyst downgrades, media coverage, trading patterns, or missed milestones, causing a slow cumulative decline. Courts treat these claims more skeptically than claims built on identifiable disclosure events, because distinguishing a genuine information leak from ordinary volatility is hard. A leakage case usually still needs an anchor: a final corrective event that confirms the full truth. Without one, the argument can look like a complaint that the stock went down.
Materialization of Risk
A corrective disclosure is not the only route. Under the materialization of risk theory, accepted by most federal circuits, the plaintiff shows that a defendant’s misstatements concealed a foreseeable risk that later came to pass and caused a price decline.
Consider a pharmaceutical company that tells investors its flagship drug is on track for approval while hiding serious safety data. No one publicly corrects the misstatement. Six months later, the FDA rejects the drug based on the very safety issues the company hid, and the stock craters. The plaintiff does not have to identify a moment when someone said “the company lied.” The concealed risk itself materialized, and the resulting loss is traceable to the fraud.
Two things have to line up: the risk that materialized has to fall within the zone of risk the misrepresentation concealed, and that materialization has to be what moved the price. The Ninth Circuit has confirmed there is no blanket requirement that the fraud be publicly revealed before the loss occurs. What matters is proximate cause.5Ninth Circuit District and Bankruptcy Courts. Manual of Model Civil Jury Instructions – 18.8 Securities Causation
Event Studies and Expert Evidence
Loss causation claims live or die on quantitative evidence. The standard tool is an event study, a statistical analysis performed by a financial economist. The expert compares the stock’s actual return on the day of a corrective disclosure against what the return should have been based on broader market movements, typically using a benchmark like the S&P 500. The gap between predicted and actual return is the “abnormal return.” If it is statistically significant, the expert can attribute a specific dollar amount or percentage of the decline to the disclosure rather than market noise.
The analysis uses a narrow window around the disclosure date to capture the immediate reaction. A well-constructed event study gives the jury a concrete number, which is far more persuasive than general claims that the stock fell after bad news. Courts now treat event studies as the expected form of proof, and a plaintiff without one is fighting uphill.
Challenging the Study
Defense experts attack event studies as a matter of course. Common challenges target the methodology. In periods of high market volatility, standard statistical models can overidentify significant price movements, flagging fraud-related declines where none exist. A defense expert may argue the model failed to account for changing conditions during the estimation period, or that the benchmark index was poorly chosen.
Defendants can also challenge admissibility under Daubert, arguing the methodology is unreliable or the error rate too high. Alternative models that correct for volatility shifts can produce very different results. These expert battles often decide the case, and judges who are not statisticians have to evaluate which methodology is more credible. Both sides need economists who can explain the work in plain terms.
Separating Fraud From Market Noise
A plaintiff has to account for every other plausible reason the stock dropped. A recession, a rate hike, a competitor’s new product, a regulation hitting the whole industry: any of these can push a stock down regardless of fraud. Defendants will press these alternative explanations hard.
The fraud does not have to be the sole cause. It has to be a “substantial factor” in causing the decline.5Ninth Circuit District and Bankruptcy Courts. Manual of Model Civil Jury Instructions – 18.8 Securities Causation Isolating the fraud-related portion from the market-driven portion is where event studies earn their keep. A properly designed study filters out market-wide and industry-wide movements and leaves the residual decline attributable to the disclosure.
Defendants also point to intervening events that break the causal chain. If a major geopolitical crisis hit between the misstatement and the disclosure, the defense will argue the crisis caused the loss, not the fraud. Courts take these arguments seriously, because awarding damages for losses the defendant did not cause is exactly what the doctrine exists to prevent.
How Damages Are Capped
Proving loss causation does not give the plaintiff unlimited damages. The PSLRA caps recovery at the difference between the price the plaintiff paid and the mean trading price of the security over the 90-day period after the corrective information reaches the market.2Office of the Law Revision Counsel. 15 USC 78u-4 – Private Securities Litigation
The lookback exists because stock prices often recover some ground after an initial crash. If a stock drops from $50 to $30 on the day of a corrective disclosure and climbs back to $40 over the next three months, damages are measured against the 90-day average, not the worst single day. The statute defines “mean trading price” as the average of daily closing prices during that window.2Office of the Law Revision Counsel. 15 USC 78u-4 – Private Securities Litigation
If the plaintiff sells before the 90 days expire, damages are capped at the difference between the purchase price and the mean trading price from the disclosure date through the sale date. That prevents plaintiffs from locking in losses at the bottom and claiming damages measured against a lower average.
Deadlines That Can End the Case
A loss causation analysis is worthless if the plaintiff misses the filing deadline. For private securities fraud claims under the Exchange Act, the statute of limitations gives the plaintiff two years from the date they discovered, or should have discovered through reasonable diligence, the facts behind the violation. A separate five-year statute of repose runs from the date of the violation itself, regardless of when the plaintiff learned about it.6Office of the Law Revision Counsel. 28 USC 1658 – Time Limitations on the Commencement of Civil Actions Arising Under Acts of Congress
These deadlines interact with loss causation in a hard way. If a corrective disclosure comes four years after the fraud, only one year is left before the repose period closes, which is very little time to assemble the expert evidence, event studies, and detailed pleadings the doctrine demands. Claims under the Securities Act of 1933 face even shorter windows: one year from discovery with a three-year repose period.7Office of the Law Revision Counsel. 15 USC 77m – Limitation of Actions
Loss Causation at Class Certification
In class action litigation, loss causation gets more complicated because thousands of investors with different purchase and sale dates have to show a common causal link. In Halliburton Co. v. Erica P. John Fund, Inc. (2014), the Supreme Court confirmed that while the fraud-on-the-market presumption of reliance remains available to class plaintiffs, defendants can challenge it at the class certification stage by presenting evidence that the alleged misrepresentation had no price impact.4Justia. Halliburton Co. v. Erica P. John Fund, Inc., 573 U.S. 258 (2014)
The Court called price impact “an essential precondition for any Rule 10b-5 class action” and held that defendants should not have to wait until the merits stage to introduce direct evidence that the misstatement never moved the stock price.4Justia. Halliburton Co. v. Erica P. John Fund, Inc., 573 U.S. 258 (2014) If the defendant can show the price did not react to the misrepresentation when it was made, the class falls apart before trial, because without price impact there is no common mechanism linking the fraud to each investor’s loss.
Class certification hearings now routinely involve the same dueling event studies that appear at the damages stage. The plaintiff’s expert presents a study showing statistically significant price movement tied to the misstatement and the corrective disclosure. The defendant’s expert presents a competing study arguing the movements were caused by other factors or were not statistically significant at all. Judges have to evaluate these competing analyses without resolving the ultimate merits, a line courts acknowledge is difficult to walk.